PFS evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-25T23:39:30.299016+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 5182500000.0
- net_income
- 3193600000.0
- operating_cash_flow
- 2204700000.0
- free_cash_flow
- 2201600000.0
- total_assets
- 49562500000.0
- total_liabilities
- 18765300000.0
- total_equity
- 30797200000.0
- cash
- 919600000.0
- total_debt
- 17681100000.0
- revenue_growth
- -0.06522248877184755
- earnings_growth
- 0.4713660446901635
- net_margin
- 0.6162276893391221
- roe
- 0.10369773875547128
- debt_to_equity
- 0.5741138804826412
- cash_conversion
- 0.6903494488977956
- free_cash_flow_margin
- 0.4248142788229619
- trailing_pe
- 10.27
- forward_pe
- Not supplied
- peg_ratio
- Not supplied
- price_to_book
- Not supplied
- dividend_yield
- Not supplied
Other positional research
No qualifying opportunity
No candidate at another positional horizon in the coherent source run.
- No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
- Decision ID
- decision-ab55ea0847b444d20c789123e983e3965272f76b610bdaef4d0221b6e81f60af
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 2f1b27864eddb5cdb19b9d170e322dbb49f9cf6d9431d1d789a4959411df5230
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 2cb01fbe1e3e26a271d17144bfc89d0197f7c58955f941450b9fed19b51fd6d3
- daily-price: b3b22d46edf3a66a19e9ecfdeebc85eb72e305283b00cf0c4a39fdcad2fbb074
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 28.81.
- The trailing 5-session price return was 6.98%.
- The trailing 20-session price return was 6.23%.
- The trailing 60-session price return was -5.94%.
- The trailing 250-session price return was -21.05%.
- Average cached traded value over twenty sessions was INR 76,905,196.
- The closing price was -26.99% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-25T23:39:30.299016+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is -0.06522248877184755.
- The cached financial metric net margin is 0.6162276893391221.
- The cached financial metric roe is 0.10369773875547128.
- The cached financial metric debt to equity is 0.5741138804826412.
- The cached financial metric cash conversion is 0.6903494488977956.
- The cached financial metric free cash flow margin is 0.4248142788229619.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.